AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
July 2025
Parkinsons' disease

Association between alcohol consumption and mortality in Parkinson’s disease

Previous studies on the association between alcohol consumption and risk of Parkinson’s disease (PD) have produced controversial results. However, the relationship between alcohol consumption and mortality in PD has scarcely been investigated. Among the nationwide population data from Korea National Health Insurance Service, newly diagnosed PD (ICD-10 code: G20 and a rare intractable disease registration code: V124), between 2009 and 2017, were selected.
Alcohol consumption habit was obtained from a self-reported questionnaire on the National Health Screening Program. 32,419 individuals with PD were followed-up longitudinally until December 31, 2017, and all-cause mortality was evaluated. During the follow-up period (mean 4.37 ± 2.67 years), 9,049 deaths occurred.
When non-drinkers are used as a reference group, there were significant associations between alcohol consumption and all-cause mortality in mild (hazard ratio [HR] 0.78, 95% confidence interval [CI] 0.71-0.84) and moderate drinkers (HR 0.69, 95% CI 0.58-0.82), but not in heavy drinkers (HR 0.84, 95% CI 0.69-1.02). In the sensitivity analysis using never drinkers as the reference group, the results also showed an overall 20% reduced mortality risk among drinkers with PD. Regarding changes in alcohol consumption behaviour before and after diagnosis, the mortality rate was higher in former drinkers (HR 1.20, 95% CI 1.02-1.41) and lower in constant drinkers (HR 0.74, 95% CI 0.65-0.83) than in never drinkers.
Alcohol consumption appears to be associated with reduced all-cause mortality in PD, suggesting potential neuroprotective effects on disease progression. Although drinking does not appear to be detrimental to all-cause mortality in individuals with PD, alcohol consumption in PD requires attention considering individual motor and non-motor symptoms. Future studies in other ethnic groups are warranted to validate the association between alcohol consumption and disease progression, including mortality, in PD.
Source: Park YH, Kim YW, Kang DR, et al. Association between alcohol consumption and mortality in Parkinson’s disease. J Neural Transm. 2025.

doi.org/10.1007/s00702-025-02976-2.
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Rheumatoid arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Health effects associated with alcohol consumption: a Burden of Proof study

Alcohol consumption and the risk of dementia in patients with depression: A nationwide cohort study

The health impacts of alcohol depend on what you drink – and how much

Metabolome contribution to sex differences in the link between alcohol consumption and type 2 diabetes

Rising global burden of alcohol-attributable breast cancer in women: Regional inequalities and temporal trends

Aim Digest

April 2026

February 2026

January 2026

December 2025

November 2025

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy